This filing is administrative and contains no trading signal. Monitor future insider Form 4 filings for open-market purchases or sales by Hoerter, which would provide actionable information.
Price Chart
Executive Summary
Steven Hoerter filed a Form 3 initial statement of beneficial ownership after Yarrow Bioscience (formerly VYNE Therapeutics) completed a merger where a VYNE subsidiary merged into Yarrow, with Yarrow surviving as a wholly owned subsidiary and VYNE changing its name to Yarrow Bioscience, Inc. The filing discloses options to purchase 87,820 shares of common stock at $6.19 per share, received in exchange for pre-merger Yarrow options. This is a routine post-merger insider filing with no new economic information for traders.
Key Facts
- Form 3 filed by Steven Hoerter, reporting beneficial ownership after a merger closed on July 27, 2026.
- Hoerter holds options to buy 87,820 shares of Yarrow Bioscience common stock at $6.19 per share, vesting over four years starting April 17, 2027.
- The merger involved a VYNE subsidiary merging into Yarrow, with Yarrow surviving as a wholly owned subsidiary and VYNE renamed to Yarrow Bioscience, Inc.
Financial Impact
No new financial impact — the filing is a routine initial ownership statement post-merger.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001104659-26-088360 |
| Document: 0001104659-26-088360-index-headers.html | 0001104659-26-088360 |
| Document: 0001104659-26-088360-index.html | 0001104659-26-088360 |
| Document: 0001104659-26-088360.txt | 0001104659-26-088360 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 20d ago | SC 13G | No price | awaiting T+20 | awaiting T+20 | No price |
Jul 29, 2026 12w ago | 3 | $28.05 | awaiting T+20 | awaiting T+20 | No price |
Jul 21, 2026 14w ago | 8-K | $0.8927 | awaiting T+20 | awaiting T+20 | No price |
Jul 14, 2026 15w ago | 425 / 8-K | $0.7110 | awaiting T+20 | awaiting T+20 | No price |
Jul 10, 2026 15w ago | 425 / 8-K | $0.6376 | awaiting T+20 | awaiting T+20 | No price |
Jun 17, 2026 19w ago | EFFECT | $0.6311 $0.7675 | ▲ +21.61% | ▲ +20.30% | No price |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers